Conference Coverage

VIDEO: Watch for anxiety, other symptoms in cannabis users on anti-cannabinoids


 

AT THE SUMMIT IN NEUROLOGY & PSYCHIATRY

References

WASHINGTON – The physical withdrawal symptoms of cannabis users given anti-cannabinoids resemble those of people withdrawing from opioid use by taking naloxone, according to Dr. Mark S. Gold. In this interview, recorded at the Summit in Neurology & Psychiatry sponsored by the Global Academy for Medical Education, Dr. Gold of the department of psychiatry at Washington University in St. Louis, describes withdrawal from cannabis, including symptoms of anxiety, panic, and confusion. Global Academy and this news organization are owned by the same company.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

‘Dabbing’ on the rise: Is this marijuana use dangerous?
MDedge Family Medicine
ICOO: Quality metrics needed for medical marijuana
MDedge Family Medicine
Medical marijuana legalization not tied to uptick in teen use
MDedge Family Medicine
ICOO: Opioids blurring criminal activity and malpractice
MDedge Family Medicine
To sleep, perchance to reprogram behaviors?
MDedge Family Medicine
Legislation aims to improve treatment of serious mental illness
MDedge Family Medicine
Morphine synthesis finding paves way for new painkillers
MDedge Family Medicine
Carrots and sticks lead to smoking cessation
MDedge Family Medicine
WCD: Smoking tied to worse occupational hand eczema
MDedge Family Medicine
VIDEO: Beware of dehydration, hyperthermia in drug-taking concert-goers, or ‘ravers’*
MDedge Family Medicine